Education
About Us
Working with TipRanks
Follow Us
Indo US Bio-Tech Ltd. (IN:INDOUS)
:INDOUS
INDOUS Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹131.00 - ₹386.00
Previous CloseN/A
Volume1.20K
Average Volume (3M)1.88K
Market Cap
₹2.83B
Enterprise Value₹6.04B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)15.9
Beta0.85
Next Earnings
Nov 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.35
Shares Outstanding20,052,000
10 Day Avg. Volume2,218
30 Day Avg. Volume1,882
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Indo US Bio-Tech Ltd. News
INDOUS FAQ
What was Indo US Bio-Tech Ltd.’s price range in the past 12 months?
Indo US Bio-Tech Ltd. lowest stock price was ₹131.00 and its highest was ₹386.00 in the past 12 months.
What is Indo US Bio-Tech Ltd.’s market cap?
Indo US Bio-Tech Ltd.’s market cap is ₹2.83B.
When is Indo US Bio-Tech Ltd.’s upcoming earnings report date?
Indo US Bio-Tech Ltd.’s upcoming earnings report date is Nov 13, 2025 which is in 40 days.
How were Indo US Bio-Tech Ltd.’s earnings last quarter?
Indo US Bio-Tech Ltd. released its earnings results on Aug 12, 2025. The company reported ₹2.345 earnings per share for the quarter, beating the consensus estimate of N/A by ₹2.345.
Is Indo US Bio-Tech Ltd. overvalued?
According to Wall Street analysts Indo US Bio-Tech Ltd.’s price is currently Overvalued.
Does Indo US Bio-Tech Ltd. pay dividends?
Indo US Bio-Tech Ltd. does not currently pay dividends.
What is Indo US Bio-Tech Ltd.’s EPS estimate?
Indo US Bio-Tech Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Indo US Bio-Tech Ltd. have?
Indo US Bio-Tech Ltd. has 20,052,000 shares outstanding.
What happened to Indo US Bio-Tech Ltd.’s price movement after its last earnings report?
Indo US Bio-Tech Ltd. reported an EPS of ₹2.345 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.56%.
Which hedge fund is a major shareholder of Indo US Bio-Tech Ltd.?
Currently, no hedge funds are holding shares in IN:INDOUS
Technical Analysis
Bal Pharma Limited
―
Biofil Chemicals & Pharmaceuticals Ltd.
―
Ind-Swift Ltd.
―
Krebs Biochemicals & Industries Ltd.
―
Venus Remedies Limited
―